famotidine and fluticasone

famotidine has been researched along with fluticasone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Doi, S; Kameda, M; Nishikido, T; Takamatu, I; Yoshida, Y	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1

Other Studies

2 other study(ies) available for famotidine and fluticasone

Article	Year
[Gastroesophageal reflux disease in preschool children with asthma]. Arerugi = [Allergy], 2008, Volume: 57, Issue:5 Topics: Androstadienes; Asthma; Child, Preschool; Diagnosis, Differential; Esophageal pH Monitoring; Famotidine; Fluticasone; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant; Recurrence; Retrospective Studies	2008
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004

Article

Year

[Gastroesophageal reflux disease in preschool children with asthma].

Arerugi = [Allergy], 2008, Volume: 57, Issue:5

Topics: Androstadienes; Asthma; Child, Preschool; Diagnosis, Differential; Esophageal pH Monitoring; Famotidine; Fluticasone; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant; Recurrence; Retrospective Studies

2008

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004